Structured Product Labeling (SPL) HT9426-26-Q-E022

The contract issued by the Office of Regulated Activities within the DHA Research & Development Medical Research and Development Command focuses on managing, processing, and completing initial labeling and labeling changes for electronic Structured Product Label (SPL) document submissions to the FDA. SPL follows the Health Level Seven (HL7) standard, which is based on Clinical Document Architecture and the HL7 Reference Information Model and is accredited by ANSI for exchanging product information. The DHA R&D MRDC currently holds two licensed New Drug Application products necessitating SPL submissions covering up to five levels of primary and secondary labeling. This solicitation, titled "Structured Product Labeling (SPL)," was posted on May 15, 2026, with responses due by June 5, 2026. It is a combined contract type under NAICS code 541690, managed by the Army Medical Resources Acquisition Activity, a Department of Defense office located in Fort Detrick, Maryland. Performance will take place in Frederick, MD. The primary point of contact is Matthew Gembe, and the contracting officer is Terrie Bloom. The contract does not specify any set-aside provisions.